Patent US6165200A successfully refreshed from Google Patents.
US5554147A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Compositions and devices for controlled release of active ingredients
Assignee: CApHCO Inc
•
Filing: 1994-02-01
•
Granted: 1996-09-10
•
Expires: 2014-02-01
Abstract
Abstract A method for the controlled release of a biologically active agent wherein the agent is released from a hydrophobic, pH-sensitive polymer matrix is disclosed and claimed. The polymer matrix swells when the environment reaches pH 8.5, releasing the active agent. A polymer of hydrophobic and weakly acidic comonomers is disclosed for use in the controlled release system. Further disclosed is a specific embodiment in which the controlled release system may be used. The pH-sensitive polymer is coated onto a latex catheter used in ureteral catheterization. A common problem with catheterized patients is the infection of the urinary tract with urease-producing bacteria. In addition to the irritation caused by the presence of the bacteria, urease produced by these bacteria degrade urea in the urine, forming carbon dioxide and ammonia. The ammonia causes an increase in the pH of the urine. Minerals in the urine begin to precipitate at this high pH, forming encrustations which complicate the functioning of the catheter. A ureteral catheter coated with a pH-sensitive polymer having an antibiotic or urease inhibitor trapped within its matrix will release the active agent when exposed to the high pH urine as the polymer gel swells. Such release can be made slow enough so that the drug remains at significant levels for a clinically useful period of time.
Inventors
- 👤 Christopher D. Batich
- 👤 Marc S. Cohen
- 👤 Kirk Foster
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 18:22
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56; A61K31/57; A61K9/00; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2027; A61L; A61L27/00; A61L27/28; A61L27/34; A61L27/50; A61L27/54; A61L29/00; A61L29/08; A61L29/085; A61L29/14; A61L29/16; A61L31/00; A61L31/14; A61L31/16; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/60; A61L2300/602; A61L2300/606
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
108 words
A method for controlling a bacterial infection associated with the use of an indwelling medical device in an environment which is desired to be kept free of bacterial infection, wherein said infection would cause an increase in the pH of the environment of said indwelling medical device, wherein said method comprises: implanting into a patient in need of such a medical device an indwelling medical device which is coated with a biologically active agent integally incorporated throughout and trapped within a pH-sensitive polymer matrix, wherein said polymer matrix swells to release said agent at an increased rate or only upon said change of pH, thereby controlling said infection.
Claim 2
Independent Claim
108 words
A method for controlling a bacterial infection associated with the use of an indwelling medical device in an environment which is desired to be kept free of bacterial infection, wherein said infection would cause an increase in the pH of the environment of said indwelling medical device, wherein said method comprises: implanting into a patient in need of such a medical device an indwelling medical device which is coated with a biologically active agent integally incorporated throughout and trapped within a pH-sensitive polymer matrix, wherein said polymer matrix swells to release said agent at an increased rate or only upon said change of pH, thereby controlling said infection.
Claim 3
Dependent Claim
34 words
The method, according to claim 1, further comprising selecting said medical device from the group consisting of ureteral or urethral catheters or stents, heart valves, pacemakers, artificial joints, gastrointestinal tubes, intrauterine devices, and diaphragms.
Claim 4
Dependent Claim
30 words
The method, according to claim 2, further comprising selecting said environment to be urine and wherein said change in pH is to a pH which is greater than about 8.5.
Claim 5
Dependent Claim
158 words
An indwelling medical device which controls bacterial infection which causes an increase in the pH of the environment of the medical device, wherein said indwelling medical device comprises a means for inhibiting growth of bacteria which would cause said increase in pH in the environment surrounding said indwelling medical device in the absence of said means for inhibiting said growth of bacteria, wherein said means comprises a biologically active agent integrally incorporated throughout and trapped within a pH-sensitive polymer matrix coating of said indwelling device such that said agent is released from said pH-sensitive polymer matrix at an increased rate or only upon an increase in pH of the environment of the indwelling medical device above about pH 7.4 due to the commencement of bacterial growth within the environment of said indwelling medical device, wherein said increase in pH causes said pH-sensitive polymer matrix to swell to release said biologically active agent trapped within said pH-sensitive polymer matrix.
Claim 6
Dependent Claim
158 words
An indwelling medical device which controls bacterial infection which causes an increase in the pH of the environment of the medical device, wherein said indwelling medical device comprises a means for inhibiting growth of bacteria which would cause said increase in pH in the environment surrounding said indwelling medical device in the absence of said means for inhibiting said growth of bacteria, wherein said means comprises a biologically active agent integrally incorporated throughout and trapped within a pH-sensitive polymer matrix coating of said indwelling device such that said agent is released from said pH-sensitive polymer matrix at an increased rate or only upon an increase in pH of the environment of the indwelling medical device above about pH 7.4 due to the commencement of bacterial growth within the environment of said indwelling medical device, wherein said increase in pH causes said pH-sensitive polymer matrix to swell to release said biologically active agent trapped within said pH-sensitive polymer matrix.
Claim 7
Dependent Claim
16 words
The device, according to claim 4, wherein said pH-sensitive polymer matrix comprises a weakly acidic monomer.
Claim 8
Dependent Claim
23 words
The device, according to claim 5, wherein said weakly acidic monomer is selected from the group consisting of methacrylic acid and acrylic acid.
Claim 9
Dependent Claim
26 words
The device, according to claim 5, wherein said pH-sensitive polymer further comprises a hydrophobic monomer selected from the group consisting of butylmethyl acrylate and methyl methacrylate.
Claim 10
Dependent Claim
12 words
The device, according to claim 4, which is a catheter or stent.
References Cited (Backward Citations)
US3067745A
Cited
US3861396A
Cited
EP0065884A1
Cited
US4743248A
Cited
US4999210A
Cited
US5165952A
Cited
US5152758A
Cited
EP0426486A2
Cited
US5120548A
Cited
US5261896A
Cited
US5217493A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-09-10 | 2000-03-11 | 2000-09-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-09-10 | 2004-03-11 | 2004-09-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-09-10 | 2008-03-11 | 2008-09-10 | $7700.00 | Window Closed / Lapsed |